FranklinLakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced that it has elected Rebecca W. Rimel to its Board of Directors, effective today. Ms. Rimel, 61, is President and Chief Executive Officer of The Pew Charitable Trusts, a public charity that applies a rigorous, analytical approach to improving […]
BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX) announced today the pricing of its private placement of $1.0 billion in aggregate principal amount of its 6.25% Senior Notes due 2020 (the “Notes”). The offering is expected to close concurrently with the completion of Hologic’s acquisition of Gen-Probe Incorporated (NASDAQ: GPRO). The acquisition […]
LOS ANGELES — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today highlighted its comprehensive range of specialty diagnostics products at the annual conference of the American Association for Clinical Chemistry (AACC). The company continued its focus on helping customers to improve productivity by introducing products that drive innovation in the clinical […]
HATFIELD, Pa.– Genisphere has adapted its pioneering 3DNA Dendrimer Signal Amplification technology for Lateral Flow (LF) Point-of-Care (POC) assays, providing improved sensitivity and enabling a broad new array of POC tests. LF assays represent a unique and growing class of POC tests designed to rapidly diagnose patients within clinically actionable timeframes. Genisphere’s 3DNA® signal amplifiers […]
Heidelberg, – SYGNIS Pharma AG (Frankfurt: LIOK; ISIN DE000A1E9B74; Prime Standard) and GENETRIX announced today, that the biotechnology companies SYGNIS and GENETRIX have signed a binding Term Sheet under which the companies propose to combine the GENETRIX’ DNA sequencing subsidiary X-Pol Biotech and SYGNIS. Goal is to develop and market XPol Biotech, S.L.’s DNA sequencing […]
SALT LAKE CITY, UT, – Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world’s fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced it has commenced a clinical trial to evaluate the Company’s FilmArray Blood Culture Identification (BCID) Panel, which is designed to identify the numerous organisms that […]
WALTHAM, Mass. & CANOGA PARK, Calif.– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to acquire One Lambda, the leader in transplant diagnostics, for $925 million in cash, subject to a post-closing adjustment. The purchase price includes the cost of a three-year […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies’ first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions. “Genetic analysis is becoming increasingly accessible, cost-effective and a critical part of patient clinical […]
SAN DIEGO,– Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has filed a Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit from the July 5, 2012 Preliminary Injunction Order of the U.S. District Court for the Northern District of California denying […]
INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas b 123 POC system, a mobile blood gas analyzer designed for hospital point of care settings. The system’s next-generation technology helps ensure reliable performance by virtually eliminating the introduction of blood clots that can contribute to analyzer downtime and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
